Who are Candel Therapeutics, Inc.'s main suppliers?

Candel Therapeutics, Inc. (CADL) key suppliers include: Genelux Corporation, Trinity Capital Inc.. View the full supplier network at chainsifter.com/chain/CADL.

Who are Candel Therapeutics, Inc.'s major customers?

Candel Therapeutics, Inc. (CADL) key customers include: VENTAGEN, Genelux Corporation, Theriva Biologics, Inc., Trinity Capital Inc., Trinity Capital Inc. and 2 more. View the full customer network at chainsifter.com/chain/CADL.

What sector is Candel Therapeutics, Inc. in?

Candel Therapeutics, Inc. (CADL) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Candel Therapeutics, Inc. (CADL): 11 Verified Supply Chain Relationships

2Suppliers

7Customers

2Debt Items

20Related Chains

Source-Backed Evidence Depth

Candel Therapeutics, Inc. (CADL) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

12Total relationships

2Distinct source URLs

4High confidence

0.765Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Candel Therapeutics, Inc. Suppliers

Ticker	Name	Confidence	Evidence
GNLX	Genelux Corporation	72%	Reciprocal relationship from GNLX graph: Reciprocal relationship from CADL graph: Reciprocal relationship from GNLX graph: Reciprocal relationship from CADL graph: Reciprocal relationship from GNLX g…
TRIN	Trinity Capital Inc.	72%	Reciprocal relationship from TRIN graph: Reciprocal relationship from CADL graph: Reciprocal relationship from TRIN graph: Reciprocal relationship from CADL graph: Reciprocal relationship from TRIN g…

Candel Therapeutics, Inc. Customers

Ticker	Name	Confidence	Evidence
VENTAGEN	VENTAGEN	92%	Ventagen agreed to purchase from the Company all manufactured product that is required for clinical or commercial purposes at a price of cost plus 25 % of the wholesale price of the approved product
GNLX	Genelux Corporation	72%	Reciprocal relationship from GNLX graph: Reciprocal relationship from CADL graph: Reciprocal relationship from GNLX graph: ials between batches from a single supplier or between suppliers; ● the poss…
TOVX	Theriva Biologics, Inc.	72%	Reciprocal relationship from TOVX graph: Reciprocal relationship from CADL graph: Reciprocal relationship from TOVX graph: prescribe legally available drugs for off-label uses, drugs may be marketed …
TRIN	Trinity Capital Inc.	72%	Reciprocal relationship from TRIN graph: Reciprocal relationship from CADL graph: Reciprocal relationship from TRIN graph: Reciprocal relationship from CADL graph: Reciprocal relationship from TRIN g…
TRIN	Trinity Capital Inc.	72%	from such transactions. In addition, in February 2022, we borrowed $20.0 million under the four-year loan and security agreement (the SVB Loan Agreement) with Silicon Valley Bank (SVB). On October 14…
NC-INCORPORATED	NC-INCORPORATED	62%	thereunder; • our ability to enter into agreements with contract development and manufacturing organizations (CDMOs) for the development, clinical manufacture and commercial manufacture of our produc…
Q-EMERGING-GROWTH-COMPANY	Q-EMERGING-GROWTH-COMPANY	62%	; • the scope, progress, results, and costs of any product candidates that we may derive from our HSV-based platform or with collaborators; • the costs of preparing, filing and prosecuting patent app…

Candel Therapeutics, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
CADL-DEBT-8450	Warrants outstanding: 430000	90%	xbrl warrant detail from xbrl 2025-12-31.
CADL-DEBT	Debt stack $1.7M	90%	Market cache reports total debt of $1.7M.

Candel Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Candel Therapeutics, Inc..

Candel Therapeutics, Inc. Ownership

Holder	Name	Confidence	Evidence
CADL-OWNER-FMR-LLC	FMR LLC	90%	13F overlay lists FMR LLC as top holder; 115 tracked holders.

Candel Therapeutics, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
TOVX	Theriva Biologics, Inc.	100.00	1	['customer']
RPID	Rapid Micro Biosystems, Inc.	100.00	2
GNLX	Genelux Corporation	100.00	1	['customer', 'supplier']
TRIN	Trinity Capital Inc.	100.00	1	['customer', 'supplier']
TSHA	Taysha Gene Therapies, Inc.	100.00	2
SI	Shoulder Innovations, Inc.	100.00	2
BMYMP	Bristol-Myers Squibb Co	50.00	2
ONCY	Oncolytics Biotech Inc.	50.00	2
MCRB	Seres Therapeutics, Inc.	50.00	2
RGTI	Rigetti Computing, Inc.	50.00	2
REPL	Replimune Group, Inc.	50.00	2
IOVA	Iovance Biotherapeutics, Inc.	50.00	2
JNJ	Johnson & Johnson	50.00	2
CLDWW	Calidi Biotherapeutics, Inc.	50.00	2
LLY	Eli Lilly and Company	50.00	2
CORZ	Core Scientific, Inc.	50.00	2
CELG-RI	BRISTOL MYERS SQUIBB CO	50.00	2
REGN	Regeneron Pharmaceuticals, Inc.	50.00	2
CGON	CG Oncology, Inc.	50.00	2
BMY	Bristol-Myers Squibb Company	50.00	2

Candel Therapeutics, Inc. Supply Chain